Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination bo...
Main Authors: | Zeno Bisoffi, Nicoletta De Santis, Chiara Piubelli, Michela Deiana, Francesca Perandin, Pietro Girardi, Luca Heller, Natalia Alba, Carlo Pomari, Massimo Guerriero |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2023-04-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/29/4/22-1268_article |
Similar Items
-
Prevalence of SARS-CoV-2, Verona, Italy, April–May 2020
by: Massimo Guerriero, et al.
Published: (2021-01-01) -
Impact of Full Vaccination with mRNA BNT162b2 on SARS-CoV-2 Infection: Genomic and Subgenomic Viral RNAs Detection in Nasopharyngeal Swab and Saliva of Health Care Workers
by: Michela Deiana, et al.
Published: (2021-08-01) -
sgRNAs: A SARS-CoV-2 emerging issue
by: Antonio Mori, et al.
Published: (2023-01-01) -
Blastocystis prevalence and subtypes in autochthonous and immigrant patients in a referral centre for parasitic infections in Italy.
by: Chiara Piubelli, et al.
Published: (2019-01-01) -
Droplet Digital PCR for the Detection of <i>Plasmodium falciparum</i> DNA in Whole Blood and Serum: A Comparative Analysis with Other Molecular Methods
by: Elena Pomari, et al.
Published: (2020-06-01)